Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 19, 2020 07:00 ET | Source: Surrozen, Inc.

Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials

SOUTH SAN FRANCISCO, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the successful...
May 04, 2020 10:00 ET | Source: Surrozen, Inc.

Surrozen Announces Publication of Two Abstracts Providing Evidence for Liver-Targeted Tissue Regeneration

-- Abstracts originally accepted for 2020 Digestive Disease Week Conference – to be published online -- SOUTH SAN FRANCISCO, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a...
April 06, 2020 10:00 ET | Source: Surrozen, Inc.

Surrozen Scientific Founder Roel Nusse, PhD Receives Prestigious Canada Gairdner International Award for Biomedical Research

SOUTH SAN FRANCISCO, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced that one of its...
March 30, 2020 13:42 ET | Source: Surrozen, Inc.

Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology

-- Novel approach to creating Wnt-mimetics establishes proof-of-concept for targeted regenerative antibodies -- SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a...
March 02, 2020 10:00 ET | Source: Surrozen, Inc.

Surrozen to Present at Cowen and Company 40th Annual Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Surrozen, Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues,...
April 11, 2019 10:01 ET | Source: Surrozen, Inc.

Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer

SOUTH SAN FRANCISCO, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Surrozen Inc., a company discovering and developing novel antibodies for regenerative medicine with a focus on specific control of the...
March 14, 2019 10:00 ET | Source: Surrozen, Inc.

Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates

-- Anna Berkenblit, MD, appointed to Surrozen Board of Directors -- SAN FRANCISCO, March 14, 2019 (GLOBE NEWSWIRE) -- Surrozen Inc., a company discovering and developing novel antibodies for...